Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir Plus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic Patients Infected with HCV Genotype 4
Article in Current Drug Safety (January 2023)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Article in Current Drug Safety (January 2023)
Article in Diagnostics (November 2021)
Article in European Journal of Gastroenterology & Hepatology (January 2021)